KinBio

Overview
Biosimilars?
Product stageSegments
Early
?
Contract Development and Manufacturing Organizations
?

KinBio is a biotechnology company focused on the development of innovative treatments for chronic and rare diseases. The company leverages its proprietary drug discovery platform to identify and advance novel therapeutic candidates targeting various biological pathways.

KinBio's pipeline includes several drug candidates in different stages of clinical development. The lead program is a small molecule therapy for the treatment of a rare genetic disorder. This investigational drug has received orphan drug designation from regulatory authorities and is currently being evaluated in a Phase 2 clinical trial.

In addition to its rare disease focus, KinBio is also pursuing the development of therapies for more prevalent chronic conditions. One of these programs is a monoclonal antibody targeting an undisclosed immune system pathway, which is in the preclinical research stage.

The company has established strategic partnerships with several leading academic research institutions and pharmaceutical companies to accelerate its drug discovery and development initiatives. KinBio's partners provide complementary expertise and resources to supplement the company's internal capabilities.

Headquartered in a major biotech hub, KinBio operates research and development facilities equipped with advanced drug discovery technologies. The company's scientific team comprises experienced industry veterans and renowned academic researchers.


Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
12 Hamada st Rehovot ISR
Founded year:
2019
Employees:
11-50
IPO status:
Private
Total funding:
-
Last Funding:
-
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.